Exogenous ATP-induced lipolysis and its correlation with skeletal muscle atrophy and hepatic damage in fasting mice.

Eur J Pharmacol

Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Druggability Research for Cerebrovascular Diseases, Institute of Materia Medica of Peking Union Medical College, Beijing, PR China. Electronic address:

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Adenosine triphosphate (ATP) is a critical energy currency in living organisms, yet its extracellular transport and efficacy as an exogenous energy source remain controversial. This study explored the effects of exogenous ATP administration on energy metabolism and tissue integrity in fasting mice. C57BL/6J mice were intraperitoneally injected with ATP at doses of 25, 50, and 100 mg/kg every 12 h during a 72-h fasting period. While ATP did not significantly alter body weight, higher doses elevated blood ketone and free fatty acids levels with reducing lactate concentrations. At the tissue level, ATP exacerbated fasting-induced fat loss and aggravated skeletal muscle atrophy, as evidenced by reducing gastrocnemius muscle fiber cross-sectional areas and increasing expression of atrophy markers F-box only protein 32 (Atrogin-1) and muscle-specific RING-finger 1 (Murf-1). Additionally, high-dose ATP (100 mg/kg) significantly increased plasma levels of liver injury markers alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating hepatic damage. RNA sequencing and Western blot analyses revealed that ATP administration reduced lipid synthesis and enhanced lipolysis, leading to elevated free fatty acid levels in plasma and tissues. These findings suggest that exogenous ATP fails to improve energy metabolism during fasting and may instead promote lipolysis, thereby exacerbating skeletal muscle atrophy and hepatic injury. The study highlights the potential adverse effects of exogenous ATP under fasting conditions, emphasizing the need for further investigation into its mechanisms and clinical implications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2025.177978DOI Listing

Publication Analysis

Top Keywords

skeletal muscle
12
muscle atrophy
12
exogenous atp
12
atp
9
atrophy hepatic
8
hepatic damage
8
fasting mice
8
effects exogenous
8
atp administration
8
energy metabolism
8

Similar Publications

Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

Am J Forensic Med Pathol

September 2025

Department of Pathology, St Louis University School of Medicine, Office of the Medical Examiner - City of St. Louis, St. Louis, MO.

Myotonic dystrophy type 1, or dystrophia myotonica type 1 (DM1), is a multisystem disorder inherited in an autosomal dominant manner. It is caused by a CTG tri-nucleotide expansion in the 3'-untranslated region (3'-UTR) of the dystrophia myotonia protein kinase (DMPK) gene. Core clinical features include progressive skeletal muscle weakness, myotonia, and systemic complications, with premature mortality most often due to respiratory or cardiac dysfunction.

View Article and Find Full Text PDF

Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.

Neuropathol Appl Neurobiol

October 2025

Division of Rheumatology and Systemic Inflammatory Diseases, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Aims: Sarcoid myopathy (SaM) is characterised by granulomatous myositis (GM) and can overlap with inclusion body myositis (IBM), a late-onset chronic idiopathic inflammatory myopathy with a still enigmatic pathogenesis. As GM can occur in different clinical contexts, we aimed to examine the histomorphologic features and gene expression profiles in cases of definite SaM that may inform diagnostic and therapeutic considerations.

Methods: We performed a multidimensional characterisation of muscle biopsy specimens from patients with 'pure SaM' (n=17), SaM with concomitant IBM (SaM-IBM) (n=2), including histopathologic and ultrastructural analysis in addition to quantitative real-time polymerase chain reaction.

View Article and Find Full Text PDF

Background: Fine particulate matter has developmental toxicity, and midgestation is an important period for the development of foetal skeletal muscle. The ability of exercise to modulate skeletal muscle damage in mice exposed to PM during gestation remains unclear.

Methods: Pregnant C57BL/6 mice were exposed to 50 μg/m PM for 2 h on five consecutive days starting at embryonic day 12.

View Article and Find Full Text PDF

Purpose: CL316,243 (CL), a beta 3 adrenergic receptor (B3-AR) agonist has 'exercise mimetic' effects in adipose tissue (AT). CL may also positively affect skeletal muscle (SM), yet the role of estrogen receptor beta (ERβ) in mediating SM-specific effects of CL is not known. We investigated the effects of CL on SM metabolism, as well as the role played by ERβ.

View Article and Find Full Text PDF

A myotropic AAV vector combined with skeletal muscle -regulatory elements improve glycogen clearance in mouse models of Pompe disease.

Mol Ther Methods Clin Dev

June 2025

Université Paris-Saclay, University Evry, Inserm, Genethon, Integrare Research Unit UMR_S951, 91000 Evry, France.

Pompe disease is a glycogen storage disorder caused by mutations in the acid α-glucosidase (GAA) gene, leading to reduced GAA activity and glycogen accumulation in heart and skeletal muscles. Enzyme replacement therapy with recombinant GAA, the standard of care for Pompe disease, is limited by poor skeletal muscle distribution and immune responses after repeated administrations. The expression of GAA in muscle with adeno-associated virus (AAV) vectors has shown limitations, mainly the low targeting efficiency and immune responses to the transgene.

View Article and Find Full Text PDF